Homology-mediated end joining-based targeted integration using CRISPR/Cas9

Cell Research

Volumn 27, Issue 6, 2017, Pages 801-814

  Yao, Xuan ^a,b   Wang, Xing ^a,b   Hu, Xinde ^a   Liu, Zhen ^a   Liu, Junlai ^b,c,d   Zhou, Haibo ^a   Shen, Xiaowen ^a   Wei, Yu ^a,e   Huang, Zijian ^a,b   Ying, Wenqin ^a   Wang, Yan ^a   Nie, Yan Hong ^a   Zhang, Chen Chen ^a   Li, Sanlan ^a   Cheng, Leping ^a   Wang, Qifang ^a   Wu, Yan ^f   Huang, Pengyu ^c   Sun, Qiang ^a   Shi, Linyu ^a   Yang, Hui ^a   more..

^a Chinese Academy of Sciences   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c SHANGHAITECH UNIVERSITY   (China)

^d INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^e SHANGHAI UNIVERSITY   (China)

^f NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES   (China)

Author keywords

CRISPR Cas9; Homology mediated end joining; Knock in; Monkey embryos; Neurons

Indexed keywords

GUIDE RNA;

ANIMAL; CRISPR CAS SYSTEM; DNA END JOINING REPAIR; GENE KNOCK-IN; GENETIC ENGINEERING; GENETICS; HEK293 CELL LINE; HUMAN; LIVER CELL; METABOLISM; MOUSE; PHYSIOLOGY; PROCEDURES;

ANIMALS; CRISPR-CAS SYSTEMS; DNA END-JOINING REPAIR; GENE KNOCK-IN TECHNIQUES; GENETIC ENGINEERING; HEK293 CELLS; HEPATOCYTES; HUMANS; MICE; RNA, GUIDE;

EID: 85020233569     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2017.76     Document Type: Article

References (30)

1. Yang H, Wang H, Shivalila CS, Cheng AW, Shi L, Jaenisch R. One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering. Cell 2013; 154:1370-1379.
2. Hockemeyer D, Wang H, Kiani S, et al. Genetic engineering of human pluripotent cells using TALE nucleases. Nat Biotechnol 2011; 29:731-734.
3. Kim YG, Cha J, Chandrasegaran S. Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain. Proc Natl Acad Sci USA 1996; 93:1156-1160.
4. Bibikova M, Beumer K, Trautman JK, Carroll D. Enhancing gene targeting with designed zinc finger nucleases. Science 2003; 300:764.
5. Porteus MH, Baltimore D. Chimeric nucleases stimulate gene targeting in human cells. Science 2003; 300:763.
6. Moehle EA, Rock JM, Lee YL, et al. Targeted gene addition into a specified location in the human genome using designed zinc finger nucleases. Proc Natl Acad Sci USA 2007; 104:3055-3060.
7. Christian M, Cermak T, Doyle EL, et al. Targeting DNA double-strand breaks with TAL effector nucleases. Genetics 2010; 186:757-761.
8. Mali P, Yang L, Esvelt KM, et al. RNA-guided human genome engineering via Cas9. Science 2013; 339:823-826.
9. Cong L, Ran FA, Cox D, et al. Multiplex genome engineering using CRISPR/Cas systems. Science 2013; 339:819-823.
10. Cox DB, Platt RJ, Zhang F. Therapeutic genome editing: prospects and challenges. Nat Med 2015; 21:121-131.
11. Maruyama T, Dougan SK, Truttmann MC, Bilate AM, Ingram JR, Ploegh HL. Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining. Nat Biotechnol 2015; 33:538-542.
12. Maresca M, Lin VG, Guo N, Yang Y. Obligate ligation-gated recombination (ObLiGaRe): custom-designed nuclease-mediated targeted integration through nonhomologous end joining. Genome Res 2013; 23:539-546.
13. Auer TO, Duroure K, De Cian A, Concordet JP, Del Bene F. Highly efficient CRISPR/Cas9-mediated knock-in in zebrafish by homology-independent DNA repair. Genome Res 2014; 24:142-153.
14. Nakade S, Tsubota T, Sakane Y, et al. Microhomology-mediated end-joining-dependent integration of donor DNA in cells and animals using TALENs and CRISPR/Cas9. Nat Commun 2014; 5:5560.
15. Hisano Y, Sakuma T, Nakade S, et al. Precise in-frame integration of exogenous DNA mediated by CRISPR/Cas9 system in zebrafish. Sci Rep 2015; 5:8841.
16. Sakuma T, Nakade S, Sakane Y, Suzuki KT, Yamamoto T. MMEJ-assisted gene knock-in using TALENs and CRISPR-Cas9 with the PITCh systems. Nat Protoc 2016; 11:118-133.
17. Suzuki K, Tsunekawa Y, Hernandez-Benitez R, et al. In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration. Nature 2016; 540:144-149.
18. Li J, Zhang BB, Ren YG, Gu SY, Xiang YH, Du JL. Intron targeting-mediated and endogenous gene integrity-maintaining knockin in zebrafish using the CRISPR/Cas9 system. Cell Res 2015; 25:634-637.
19. Cristea S, Freyvert Y, Santiago Y, et al. In vivo cleavage of transgene donors promotes nuclease-mediated targeted integration. Biotechnol Bioeng 2013; 110:871-880.
20. Zhang JP, Li XL, Li GH, et al. Efficient precise knockin with a double cut HDR donor after CRISPR/Cas9-mediated double-stranded DNA cleavage. Genome Biol 2017; 18:35.
21. Izpisua BJC, Callaway EM, Caddick SJ, et al. Brains, genes, and primates. Neuron 2015; 86:617-631.
22. Niu Y, Shen B, Cui Y, et al. Generation of gene-modified cynomolgus monkey via Cas9/RNA-mediated gene targeting in one-cell embryos. Cell 2014; 156:836-843.
23. Jennings CG, Landman R, Zhou Y, et al. Opportunities and challenges in modeling human brain disorders in transgenic primates. Nat Neurosci 2016; 19:1123-1130.
24. Chen Y, Zheng Y, Kang Y, et al. Functional disruption of the dystrophin gene in Rhesus monkey using CRISPR/Cas9. Hum Mol Genet 2015; 24:3764-3774.
25. Taleei R, Nikjoo H. Biochemical DSB-repair model for mammalian cells in G1 and early S phases of the cell cycle. Mut Res 2013; 756:206-212.
26. Kimura Y, Hisano Y, Kawahara A, Higashijima S. Efficient generation of knock-in transgenic zebrafish carrying reporter/driver genes by CRISPR/Cas9-mediated genome engineering. Sci Rep 2014; 4:6545.
27. Liu Y, Miao Q, Yuan J, et al. Ascl1 converts dorsal midbrain astrocytes into functional neurons in vivo. J Neurosci 2015; 35:9336-9355.
28. Sun Q, Dong J, Yang W, et al. Efficient reproduction of cynomolgus monkey using pronuclear embryo transfer technique. Proc Natl Acad Sci USA 2008; 105:12956-12960.
29. Takahashi M, Nomura T, Osumi N. Transferring genes into cultured mammalian embryos by electroporation. Dev Growth Differ 2008; 50:485-497.
30. Huang P, He Z, Ji S, et al. Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors. Nature 2011; 475:386-389.